| | Glycated cholecystokinin-8 has an enhanced satiating activity and is protected against enzymatic degradation. - ... (Site not responding. Last check: 2007-10-08) |
 | | Diabetes; 10/1/1998; Flatt, Peter R. Monoglycated cholecystokinin octapeptide (CCK-8) (glucitol-[Asp.sup.1] adduct) modified at the [NH.sub.2]-terminus was prepared under hyperglycemic conditions, purified by high-performance liquid chromatography, and characterized by mass spectrometry (Mr 1228.4 Da) and peptide sequencing. |
 | | This study demonstrated that CCK-8 is a potent short-term inhibitor of food intake, and that structural modification of this peptide by amino-terminal glycation leads to enhanced satiating activity, partially due to increased resistance to serum aminopeptidase degradation. |
 | | Cholecystokinin (CCK) is a neuropeptide hormone found in the brain and secreted from gut endocrine cells that was originally identified by its ability to stimulate gall bladder contraction (1). |
| www.highbeam.com /library/doc0.asp?DOCID=1G1:21215664&refid=holomed_1 (4491 words) |